期刊文献+

钼靶X线摄影诊断乳腺癌的评价 被引量:8

The Evaluation of Molybdenum Target Radiographic Diagnosis of Breast Tumors
暂未订购
导出
摘要 目的探讨钼靶X线摄影对乳腺癌的诊断价值。方法回顾性分析经手术、病理证实的60例乳腺癌患者的钼靶X线征象及漏误诊的原因。结果 60例患者经手术病理证实,左乳癌38例,右乳癌22例。X线表现:肿块48例,不对称性局部密度增高或结构扭曲7例,恶性钙化为主要表现5例。X线诊断正确55例(91%),误诊4例(7%),漏诊1例(2%)。结论乳腺钼靶X线检查方便,快捷实用,对乳腺癌的检出率高,对恶性钙化表现为主的早期乳腺癌的诊断有很重要的价值。乳腺癌的不典型征象及致密型乳腺是漏误诊的主要原因,任何不对称性局部密度增高,局灶性结构扭曲,较密集的微细钙化均应结合B超、MRI检查,以减少漏误诊,提高对乳腺癌的诊断准确率。 Objective To explore the value of mammography in the diagnosis of breast tumor. Methods The mammographic signs of 60 cases with breast tumor and the reasons for misdiagnosis were analyzed retrospectively. Resuits 60 cases were confirmed by pathology, left breast cancer 38 cases, while 22 cases of right breast cancer. X-ray signs included mass in 48 cases, increased local density asymmetry or structural distortion in 7 cases, malignant calcifica- tion in 5 cases. X-ray diagnosed accuracy of 55 cases(91%), misdiagnosed 4 cases(7%), missed 1 cases(2%). Conclu- sion The mammography is convenient, fast and practical, high detection rate. It is very valuable in the diagnosis of early breast tumor with malignant calcification performance-based. Atypical signs of breast cancer and dense breast are the main reason for misdiagnosis. Any asymmetry in the local density increased, the focal structural distortions, and dense micro-calcification should be combined with ultrasound, MRI examination.
出处 《西部医学》 2012年第11期2212-2214,共3页 Medical Journal of West China
基金 四川省卫生厅科研基金资助项目(编号:110615)
关键词 乳腺癌 钼靶摄影 诊断价值 评价 Breast cancer Mammography Diagnostic value Evaluation
  • 相关文献

参考文献7

二级参考文献70

共引文献126

同被引文献59

  • 1陈伟财,何劲松,王敏,吴恢升,王先明.老年乳腺癌患者新辅助内分泌治疗的临床应用[J].中国癌症杂志,2011,21(5):359-362. 被引量:23
  • 2黄水林,王索宇.45例乳腺癌X线诊断报告分析[J].实用临床医学(江西),2006,7(6):130-130. 被引量:9
  • 3鲍润贤.中华影像医学·乳腺卷[M].北京:人民卫生出版社,2002.66.
  • 4Ashish Rustogi, Ashwini Budrukkar* Ketayun Dinshaw, et al.Management of locally advanced breast cancer: Evolution andcurrent practice [J]. Clin Ter. 2007,158(5) :441-452.
  • 5Schwartz GF, Birchansky CA, Komarnicky LT, et al. Induc-tion chemotherapy followed by breast conservation for locallyadvanced carcinoma of the breast. [J]. Cancer, 1994, 73 : 362-369.
  • 6Rai Y, Sagara Y, Ooi Y. et al. Preoperative therapy using tras-tuzumab and weekly paclitaxel in a stage IIIB inoperable locallyadvanced HER2- positive breast cancer with complete pathologicresponse [J]. Gan To Kagaku Ryoho, 2009,36(3):471-473.
  • 7Lemieux J,Clemons M, Provencher L. et al. The role of neo-adjuvant her2-targeted therapies in her2-overexpressing breastcancers [J]. Curr Oncol, 2009,16(5):48-57.
  • 8El Saghir NS, Eniu A. Carlson RW, et al. Locally advancedbreast cancer: treatment guideline implementation with particu-lar attention to low- and middle-income countries [J]. Cancer.2008 Oct 15,113(8):2315-2324.
  • 9Ricardo H, Alvarez D,Booser J .et al. Phase 2 trial o. primarysystemic therapy with doxorubicin and docetaxel followed bysurgery, radiotherapy, and adjuvant chemotherapy with cyclo-phosphamide ,methotrexate, and 5-fluorouracil based on clinicaland pathologic response in patients with stage IIB to III breastcancer[J]. Cancer March, 2010,116(5):1210-1217.
  • 10von Minckwitz G, Kummel S. Vogel P. et al. Intensified neoad-juvant chemotherapy in early-responding breast cancer: phase IIIrandomized GeparTrio study[J], J Natl Cancer Inst, 2008, 100 :552-562.

引证文献8

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部